×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Celldex Therapeutics, Inc. (CLDX) NASDAQ

$43.76 0.29 (0.67%)

Market Cap: $2.90B

As of 09/06/24 04:00 PM EDT. Market closed.

(CLDX)

Celldex Therapeutics, Inc. (CLDX)
NASDAQ

$43.76
0.29 (0.67%)

Market Cap: $2.90B

As of 09/06/24 04:00 PM EDT. Market closed.

Add to Portfolio

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the ... read more

COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Anthony S. Marucci M.B.A.
Full Time Employees
160
CEO Compensation (Base)
$721,218
CEO Compensation (Total)
$8.36M
URL
Address
Perryville III Building, NJ, Hampton, 08827.
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Anthony S. Marucci M.B.A.
Full Time Employees
160
CEO Compensation (Base)
$721,218
CEO Compensation (Total)
$8.36M
Address
Perryville III Building, NJ, Hampton, 08827.
PRICE CHART FOR CELLDEX THERAPEUTICS, INC.
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$43.80
Previous Close
$43.47
Days Range
$42.78 - $44.13
52 week range
$22.11 - $53.18
Volume
498,042
Avg. Volume (30 days)
716,625
Market Cap
$2.90B
Dividend Yield
-
P/E
(15.91)
Shares Outstanding
66,287,600
Open
$43.80
Previous Close
$43.47
Days Range
$42.78 - $44.13
52 week range
$22.11 - $53.18
Volume
498,042
Avg. Volume (30 days)
716,625
Market Cap
$2.90B
Dividend Yield
-
P/E
(15.91)
Shares Outstanding
66,287,600
FINANCIAL STATEMENTS FOR CELLDEX THERAPEUTICS, INC.
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CELLDEX THERAPEUTICS, INC.
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Martin Samuel BatesSVP AND CFOJun 14, 2024 Option Exercise$10.1620,169204,99045,297Jun 18, 2024, 04:05 PM
Martin Samuel BatesSVP AND CFOJun 14, 2024 Sale$35.4217,172608,31528,125Jun 18, 2024, 04:05 PM
Crowley ElizabethSR. VP & CPDOJun 14, 2024 Option Exercise$10.3830,000311,40039,074Jun 18, 2024, 04:04 PM
Crowley ElizabethSR. VP & CPDOJun 14, 2024 Sale$34.8730,0001,045,9629,074Jun 18, 2024, 04:04 PM
Young Diane C.SVP, CHIEF MEDICAL OFFICERJun 11, 2024 Option Exercise$2.7115,00040,65017,115Jun 13, 2024, 04:05 PM
Crowley ElizabethSR. VP & CPDOJun 07, 2024 Option Exercise$9.7015,000145,47424,074Jun 11, 2024, 04:02 PM
Crowley ElizabethSR. VP & CPDOJun 07, 2024 Sale$35.0615,000525,8739,074Jun 11, 2024, 04:02 PM
Young Diane C.SVP, CHIEF MEDICAL OFFICERJun 07, 2024 Sale$35.2645,0001,586,8442,115Jun 11, 2024, 04:01 PM
Jimenez Freddy A.SVP & GENERAL COUNSELJun 05, 2024 Option Exercise$10.389,54099,02535,464Jun 07, 2024, 04:05 PM
Heath-Chiozzi MargoSVP OF REGULATORY AFFAIRSJun 03, 2024 Option Exercise$10.2564,658662,57571,752Jun 05, 2024, 04:06 PM
Heath-Chiozzi MargoSVP OF REGULATORY AFFAIRSJun 03, 2024 Sale$33.6558,3691,964,08813,383Jun 05, 2024, 04:06 PM
Wright Richard M.SR. VP & CCOJun 03, 2024 Option Exercise$18.7967,4691,267,53967,677Jun 05, 2024, 04:05 PM
Wright Richard M.SR. VP & CCOJun 03, 2024 Sale$33.7246,8441,579,35340,097Jun 05, 2024, 04:05 PM
Jimenez Freddy A.SVP & GENERAL COUNSELJun 03, 2024 Option Exercise$10.388,00683,10233,930Jun 05, 2024, 04:04 PM
Jimenez Freddy A.SVP & GENERAL COUNSELJun 03, 2024 Sale$33.608,006269,00225,924Jun 05, 2024, 04:04 PM
Heath-Chiozzi MargoSVP OF REGULATORY AFFAIRSMay 30, 2024 Option Exercise$3.7533,719126,30145,813Jun 03, 2024, 04:06 PM
Heath-Chiozzi MargoSVP OF REGULATORY AFFAIRSMay 30, 2024 Sale$34.0738,7191,319,1567,094Jun 03, 2024, 04:06 PM
Martin Samuel BatesSVP AND CFOMay 30, 2024 Option Exercise$10.3825,000259,50060,128Jun 03, 2024, 04:05 PM
Martin Samuel BatesSVP AND CFOMay 30, 2024 Sale$34.0535,0001,191,77525,128Jun 03, 2024, 04:05 PM
Cavanaugh SarahSVP OF CORP AFFAIRS & ADMIN.May 30, 2024 Option Exercise$5.8020,853120,97922,713Jun 03, 2024, 04:04 PM
Cavanaugh SarahSVP OF CORP AFFAIRS & ADMIN.May 30, 2024 Sale$33.7320,853703,3341,860Jun 03, 2024, 04:04 PM
Crowley ElizabethSR. VP & CPDOMay 30, 2024 Option Exercise$4.0142,945172,39747,671Jun 03, 2024, 04:04 PM
Crowley ElizabethSR. VP & CPDOMay 30, 2024 Sale$33.6438,5971,298,3849,074Jun 03, 2024, 04:04 PM
Jimenez Freddy A.SVP & GENERAL COUNSELFeb 13, 2024 Option Exercise$3.8624,16693,16325,924Feb 15, 2024, 04:05 PM
Martin Samuel BatesSVP AND CFOJan 02, 2024 Option Exercise$2.7810,75029,88535,128Jan 04, 2024, 04:05 PM
KELER TIBOREXECUTIVE VP & CSODec 07, 2022 Option Exercise$2.7816,86046,87124,217Dec 09, 2022, 04:07 PM
KELER TIBOREXECUTIVE VP & CSODec 07, 2022 Sale$36.9316,860622,6117,357Dec 09, 2022, 04:07 PM
Cavanaugh SarahSVP OF CORP AFFAIRS & ADMIN.Aug 18, 2022 Option Exercise$9.021,35512,2172,639Aug 19, 2022, 04:06 PM
Cavanaugh SarahSVP OF CORP AFFAIRS & ADMIN.Aug 17, 2022 Option Exercise$2.7831,31287,04732,596Aug 19, 2022, 04:06 PM
Cavanaugh SarahSVP OF CORP AFFAIRS & ADMIN.Aug 18, 2022 Sale$36.381,35549,2891,284Aug 19, 2022, 04:06 PM
Cavanaugh SarahSVP OF CORP AFFAIRS & ADMIN.Aug 17, 2022 Sale$36.7331,3121,150,2211,284Aug 19, 2022, 04:06 PM
Young Diane C.SVP, CHIEF MEDICAL OFFICERAug 17, 2022 Option Exercise$4.9964,000319,17047,115Aug 19, 2022, 04:05 PM
Young Diane C.SVP, CHIEF MEDICAL OFFICERAug 17, 2022 Sale$37.3019,000708,7152,115Aug 19, 2022, 04:05 PM
Wright Richard M.SR. VP & CCOAug 15, 2022 Option Exercise$10.3815,328159,10515,536Aug 17, 2022, 04:05 PM
Wright Richard M.SR. VP & CCOAug 15, 2022 Sale$37.7115,328578,048208Aug 17, 2022, 04:05 PM
Martin Samuel BatesSVP AND CFOAug 11, 2022 Option Exercise$9.022,45322,11726,831Aug 15, 2022, 04:16 PM
Martin Samuel BatesSVP AND CFOAug 12, 2022 Option Exercise$4.1617,54772,95341,925Aug 15, 2022, 04:16 PM
Martin Samuel BatesSVP AND CFOAug 12, 2022 Sale$36.4517,547639,62927,664Aug 15, 2022, 04:16 PM
Martin Samuel BatesSVP AND CFOAug 11, 2022 Sale$37.042,45390,85624,378Aug 15, 2022, 04:16 PM
Martin Samuel BatesSVP and CFODec 23, 2021 Option Exercise$5.687,00039,72933,878Dec 28, 2021, 04:02 PM
Martin Samuel BatesSVP and CFODec 23, 2021 Sale$42.009,500399,00024,378Dec 28, 2021, 04:02 PM
Cavanaugh SarahSVP of Corp Affairs & Admin.Dec 08, 2021 Option Exercise$10.037,32373,4817,731Dec 10, 2021, 04:03 PM
Cavanaugh SarahSVP of Corp Affairs & Admin.Dec 08, 2021 Sale$40.007,323292,920408Dec 10, 2021, 04:03 PM
Crowley ElizabethSr. VP &CPDODec 08, 2021 Option Exercise$9.024,00036,0668,726Dec 10, 2021, 04:02 PM
Crowley ElizabethSr. VP &CPDODec 08, 2021 Sale$40.004,000160,0004,726Dec 10, 2021, 04:02 PM
Heath-Chiozzi MargoSVP of Regulatory AffairsDec 08, 2021 Option Exercise$2.786001,66811,847Dec 10, 2021, 04:02 PM
Heath-Chiozzi MargoSVP of Regulatory AffairsDec 08, 2021 Sale$40.0060024,00011,247Dec 10, 2021, 04:02 PM
Martin Samuel BatesSVP and CFONov 15, 2021 Option Exercise$5.687,00039,72936,378Nov 17, 2021, 04:02 PM
Martin Samuel BatesSVP and CFONov 15, 2021 Sale$43.579,500413,88328,926Nov 17, 2021, 04:02 PM
Young Diane C.SVP, Chief Medical OfficerNov 12, 2021 Option Exercise$10.384,60047,7486,715Nov 16, 2021, 04:02 PM
Young Diane C.SVP, Chief Medical OfficerNov 12, 2021 Sale$42.944,600197,5292,115Nov 16, 2021, 04:02 PM
Cavanaugh SarahSVP of Corp Affairs & Admin.Nov 01, 2021 Option Exercise$8.035,95647,8527,731Nov 03, 2021, 04:02 PM
Cavanaugh SarahSVP of Corp Affairs & Admin.Nov 01, 2021 Sale$43.267,323316,8043,429Nov 03, 2021, 04:02 PM
Crowley ElizabethSr. VP &CPDONov 01, 2021 Option Exercise$2.788,55523,7839,043Nov 03, 2021, 04:02 PM
Crowley ElizabethSr. VP &CPDONov 01, 2021 Sale$43.294,317186,8746,515Nov 03, 2021, 04:02 PM
Heath-Chiozzi MargoSVP of Regulatory AffairsNov 01, 2021 Option Exercise$2.786001,66811,847Nov 03, 2021, 04:02 PM
Heath-Chiozzi MargoSVP of Regulatory AffairsNov 01, 2021 Sale$41.7160025,02611,247Nov 03, 2021, 04:02 PM
Heath-Chiozzi MargoSVP of Regulatory AffairsAug 11, 2021 Option Exercise$9.0210,00090,16511,247Aug 13, 2021, 06:59 AM
Jimenez Freddy A.SVP & General CounselAug 11, 2021 Buy$46.2843019,900430Aug 13, 2021, 06:58 AM
Martin Samuel BatesSVP and CFOAug 10, 2021 Option Exercise$5.7821,381123,68830,060Aug 12, 2021, 10:00 AM
Martin Samuel BatesSVP and CFOAug 10, 2021 Sale$45.252,738123,89529,378Aug 12, 2021, 10:00 AM
Marucci Anthony SPresident & CEOAug 05, 2021 Option Exercise$42.003,537148,55427,231Aug 09, 2021, 07:21 AM
Wright Richard M.Sr. VP & CCODec 14, 2020 Option Exercise$6.2120,832129,36511,665Dec 16, 2020, 04:30 PM
Wright Richard M.Sr. VP & CCODec 14, 2020 Sale$18.6120,832387,611208Dec 16, 2020, 04:30 PM
Young Diane C.SVP, Chief Medical OfficerJun 11, 2020 Buy$4.732,11510,0042,115Jun 12, 2020, 07:55 AM
Cavanaugh SarahSVP of Corp Affairs & Admin.Jun 10, 2020 Buy$4.831,0505,0711,367Jun 11, 2020, 07:54 AM
Heath-Chiozzi MargoSVP of Regulatory AffairsJun 09, 2020 Buy$3.011,0003,0051,000Jun 10, 2020, 07:55 AM
Martin Samuel BatesSVP and CFOJun 09, 2020 Buy$3.059,75029,73710,735Jun 10, 2020, 07:55 AM
MARINO JAMES JDirectorJun 09, 2020 Buy$3.008,30524,91512,704Jun 10, 2020, 07:54 AM
KELER TIBORExecutive VP & CSOJun 09, 2020 Buy$2.995,00014,9547,357Jun 10, 2020, 07:54 AM
Marucci Anthony SPresident & CEOJun 09, 2020 Buy$3.0615,00045,90019,438Jun 10, 2020, 07:54 AM
McMahon Gerald PhDDirectorDec 03, 2018 Option Exercise$0.302,824843180,697Dec 04, 2018, 07:35 AM
McMahon Gerald PhDDirectorNov 01, 2018 Option Exercise$0.312,888908183,521Nov 02, 2018, 07:50 AM
McMahon Gerald PhDDirectorOct 01, 2018 Option Exercise$0.452,8881,302186,409Oct 02, 2018, 07:32 AM
McMahon Gerald PhDDirectorSep 04, 2018 Option Exercise$0.502,8131,412189,297Sep 05, 2018, 07:59 AM
MARINO JAMES JDirectorAug 24, 2018 Buy$0.4840,00019,20065,997Aug 28, 2018, 07:34 AM
McMahon Gerald PhDDirectorAug 01, 2018 Option Exercise$0.472,8131,308192,110Aug 02, 2018, 07:55 AM
McMahon Gerald PhDDirectorJul 02, 2018 Option Exercise$0.502,8131,417194,923Jul 03, 2018, 07:43 AM
KELER TIBORExecutive VP & CSOJun 15, 2018 Buy$0.5916,5009,78335,368Jun 18, 2018, 08:15 AM
McMahon Gerald PhDDirectorJun 01, 2018 Option Exercise$0.582,8131,632197,736Jun 04, 2018, 08:15 AM
McMahon Gerald PhDDirectorMay 01, 2018 Option Exercise$0.742,8132,082200,549May 02, 2018, 07:16 AM
McMahon Gerald PhDDirectorApr 02, 2018 Option Exercise$2.333,3797,873203,362Apr 03, 2018, 07:52 AM
McMahon Gerald PhDDirectorMar 01, 2018 Option Exercise$2.253,4157,684206,741Mar 02, 2018, 07:49 AM
McMahon Gerald PhDDirectorFeb 01, 2018 Option Exercise$2.763,4159,425210,156Feb 02, 2018, 07:35 AM
McMahon Gerald PhDDirectorJan 02, 2018 Option Exercise$2.843,66510,409213,571Jan 03, 2018, 06:59 AM
McMahon Gerald PhDDirectorDec 01, 2017 Option Exercise$3.003,2129,636217,236Dec 01, 2017, 08:27 AM
McMahon Gerald PhDDirectorNov 01, 2017 Option Exercise$2.443,2127,837220,448Nov 02, 2017, 08:23 AM
McMahon Gerald PhDDirectorOct 02, 2017 Option Exercise$2.863,2129,186223,660Oct 02, 2017, 04:09 PM
McMahon Gerald PhDDirectorSep 01, 2017 Option Exercise$2.463,2127,902226,872Sep 05, 2017, 08:17 AM
McMahon Gerald PhDDirectorAug 01, 2017 Option Exercise$2.292,8696,570230,084Aug 01, 2017, 04:30 PM
McMahon Gerald PhDDirectorJul 03, 2017 Option Exercise$2.472,8697,086232,953Jul 05, 2017, 04:32 PM
McMahon Gerald PhDDirectorJun 01, 2017 Option Exercise$2.832,8698,119225,822Jun 01, 2017, 08:09 AM
McMahon Gerald PhDDirectorMay 01, 2017 Option Exercise$3.332,8699,554228,691May 01, 2017, 04:01 PM
McMahon Gerald PhDDirectorApr 03, 2017 Option Exercise$3.612,86910,357231,560Apr 03, 2017, 04:37 PM
McMahon Gerald PhDDirectorMar 01, 2017 Option Exercise$3.5432,927116,562234,429Mar 03, 2017, 09:10 AM
CATLIN AVERY WSr. VP & CFOSep 02, 2016 Option Exercise$2.8010,00028,00083,586Sep 07, 2016, 12:59 PM
KELER TIBORExecutive VP & CSOSep 02, 2016 Buy$3.323,0009,96018,868Sep 06, 2016, 01:04 PM
CATLIN AVERY WSr. VP & CFOJun 03, 2016 Option Exercise$3.0122,84768,81173,586Jun 06, 2016, 08:26 AM
CATLIN AVERY WSr. VP & CFOMar 09, 2016 Option Exercise$2.8015,00042,00050,739Mar 10, 2016, 07:59 AM
CATLIN AVERY WSr. VP & CFONov 23, 2015 Option Exercise$8.5225,000213,00060,109Nov 25, 2015, 04:09 PM
CATLIN AVERY WSr. VP & CFONov 23, 2015 Sale$18.0025,000450,00035,109Nov 25, 2015, 04:09 PM
CATLIN AVERY WSr. VP & CFOSep 11, 2015 Option Exercise$4.5010,00045,00035,109Sep 14, 2015, 08:21 AM
ELLBERGER LARRYDirectorAug 25, 2015 Buy$14.005,00070,00053,500Aug 26, 2015, 04:35 PM
ELLBERGER LARRYDirectorAug 20, 2015 Buy$15.005,00075,00048,500Aug 21, 2015, 07:01 AM
ELLBERGER LARRYDirectorAug 18, 2015 Buy$15.955,00079,74743,500Aug 19, 2015, 07:33 AM
ELLBERGER LARRYDirectorAug 13, 2015 Buy$16.595,00082,95038,500Aug 14, 2015, 08:02 AM
Marucci Anthony SPresident and CEOAug 13, 2015 Buy$16.815,80097,49750,028Aug 14, 2015, 08:01 AM
CATLIN AVERY WSr. VP & CFOJun 15, 2015 Option Exercise$8.5225,000213,00049,609Jun 16, 2015, 04:19 PM
CATLIN AVERY WSr. VP & CFOJun 15, 2015 Sale$24.5925,000614,75224,609Jun 16, 2015, 04:19 PM
CATLIN AVERY WSr. VP & CFOSep 08, 2014 Option Exercise$4.5010,00045,00024,609Sep 09, 2014, 01:53 PM
LIPTON KAREN SHOOSDirectorDec 06, 2013 Option Exercise$8.1617,728144,66031,061Dec 10, 2013, 04:20 PM
LIPTON KAREN SHOOSDirectorDec 06, 2013 Sale$24.5017,728434,33613,333Dec 10, 2013, 04:20 PM
PENNER HARRY JRDirectorDec 06, 2013 Option Exercise$8.1617,728144,66031,144Dec 10, 2013, 04:15 PM
PENNER HARRY JRDirectorDec 06, 2013 Sale$24.5017,728434,33613,416Dec 10, 2013, 04:15 PM
ELLBERGER LARRYDirectorDec 06, 2013 Option Exercise$8.1617,728144,66042,728Dec 10, 2013, 04:15 PM
ELLBERGER LARRYDirectorDec 06, 2013 Sale$24.5017,728434,33625,000Dec 10, 2013, 04:15 PM
CATLIN AVERY WSr. VP & CFODec 06, 2013 Option Exercise$8.16183,3331,495,997197,442Dec 10, 2013, 04:15 PM
CATLIN AVERY WSr. VP & CFODec 06, 2013 Sale$24.50183,3334,491,65914,109Dec 10, 2013, 04:15 PM
CATLIN AVERY WSr. VP & CFOJul 01, 2013 Option Exercise$5.955002,97514,109Jul 03, 2013, 08:51 AM
Marucci Anthony SPresident & CEOJul 01, 2013 Option Exercise$5.955002,97543,368Jul 03, 2013, 08:51 AM
KELER TIBORSr. VP & CSOAug 11, 2011 Buy$2.505,00012,52015,868Aug 11, 2011, 01:42 PM
Marucci Anthony SPresident & CEOAug 09, 2011 Buy$2.4115,00036,1605,000Aug 10, 2011, 09:54 AM
CATLIN AVERY WSr. VP & CFOAug 09, 2011 Buy$2.392,0004,7802,000Aug 10, 2011, 09:52 AM
Davis Thomas AndrewSr. VP & CMOSep 16, 2010 Buy$3.772,5009,4351,489Sep 17, 2010, 09:15 AM
LIPTON KAREN SHOOSDirectorSep 16, 2010 Buy$3.743,00011,2203,000Sep 16, 2010, 01:16 PM
PAREKH RAJESH RDirectorSep 13, 2010 Buy$3.7340,000149,34840,000Sep 14, 2010, 01:39 PM
KELER TIBORSr. VP & CSOSep 13, 2010 Buy$3.525,00017,6005,000Sep 13, 2010, 10:41 AM
Marucci Anthony SPresident & CEOSep 10, 2010 Buy$3.4511,70040,3512,500Sep 13, 2010, 10:24 AM
SHANNON TIMOTHY MDirectorSep 10, 2010 Buy$3.415,00017,0493,200Sep 13, 2010, 09:37 AM
SCHALLER CHARLES RDirectorSep 09, 2010 Buy$3.455,00017,2505,000Sep 13, 2010, 09:18 AM
PENNER HARRY JRDirectorSep 09, 2010 Buy$3.493,00010,4703,000Sep 09, 2010, 02:19 PM
CATLIN AVERY WSr. VP & CFOSep 08, 2010 Buy$3.512,0007,0162,000Sep 09, 2010, 11:57 AM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Martin Samuel BatesSVP AND CFO06/14/2024204,990
Martin Samuel BatesSVP AND CFO06/14/2024608,315
Crowley ElizabethSR. VP & CPDO06/14/2024311,400
Crowley ElizabethSR. VP & CPDO06/14/20241,045,962
Young Diane C.SVP, CHIEF MEDICAL OFFICER06/11/202440,650
Crowley ElizabethSR. VP & CPDO06/07/2024145,474
Crowley ElizabethSR. VP & CPDO06/07/2024525,873
Young Diane C.SVP, CHIEF MEDICAL OFFICER06/07/20241,586,844
Jimenez Freddy A.SVP & GENERAL COUNSEL06/05/202499,025
Heath-Chiozzi MargoSVP OF REGULATORY AFFAIRS06/03/2024662,575
Heath-Chiozzi MargoSVP OF REGULATORY AFFAIRS06/03/20241,964,088
Wright Richard M.SR. VP & CCO06/03/20241,267,539
Wright Richard M.SR. VP & CCO06/03/20241,579,353
Jimenez Freddy A.SVP & GENERAL COUNSEL06/03/202483,102
Jimenez Freddy A.SVP & GENERAL COUNSEL06/03/2024269,002
Heath-Chiozzi MargoSVP OF REGULATORY AFFAIRS05/30/2024126,301
Heath-Chiozzi MargoSVP OF REGULATORY AFFAIRS05/30/20241,319,156
Martin Samuel BatesSVP AND CFO05/30/2024259,500
Martin Samuel BatesSVP AND CFO05/30/20241,191,775
Cavanaugh SarahSVP OF CORP AFFAIRS & ADMIN.05/30/2024120,979
Cavanaugh SarahSVP OF CORP AFFAIRS & ADMIN.05/30/2024703,334
Crowley ElizabethSR. VP & CPDO05/30/2024172,397
Crowley ElizabethSR. VP & CPDO05/30/20241,298,384
Jimenez Freddy A.SVP & GENERAL COUNSEL02/13/202493,163
Martin Samuel BatesSVP AND CFO01/02/202429,885
KELER TIBOREXECUTIVE VP & CSO12/07/202246,871
KELER TIBOREXECUTIVE VP & CSO12/07/2022622,611
Cavanaugh SarahSVP OF CORP AFFAIRS & ADMIN.08/18/202212,217
Cavanaugh SarahSVP OF CORP AFFAIRS & ADMIN.08/17/202287,047
Cavanaugh SarahSVP OF CORP AFFAIRS & ADMIN.08/18/202249,289
Cavanaugh SarahSVP OF CORP AFFAIRS & ADMIN.08/17/20221,150,221
Young Diane C.SVP, CHIEF MEDICAL OFFICER08/17/2022319,170
Young Diane C.SVP, CHIEF MEDICAL OFFICER08/17/2022708,715
Wright Richard M.SR. VP & CCO08/15/2022159,105
Wright Richard M.SR. VP & CCO08/15/2022578,048
Martin Samuel BatesSVP AND CFO08/11/202222,117
Martin Samuel BatesSVP AND CFO08/12/202272,953
Martin Samuel BatesSVP AND CFO08/12/2022639,629
Martin Samuel BatesSVP AND CFO08/11/202290,856
Martin Samuel BatesSVP and CFO12/23/202139,729
Martin Samuel BatesSVP and CFO12/23/2021399,000
Cavanaugh SarahSVP of Corp Affairs & Admin.12/08/202173,481
Cavanaugh SarahSVP of Corp Affairs & Admin.12/08/2021292,920
Crowley ElizabethSr. VP &CPDO12/08/202136,066
Crowley ElizabethSr. VP &CPDO12/08/2021160,000
Heath-Chiozzi MargoSVP of Regulatory Affairs12/08/20211,668
Heath-Chiozzi MargoSVP of Regulatory Affairs12/08/202124,000
Martin Samuel BatesSVP and CFO11/15/202139,729
Martin Samuel BatesSVP and CFO11/15/2021413,883
Young Diane C.SVP, Chief Medical Officer11/12/202147,748
Young Diane C.SVP, Chief Medical Officer11/12/2021197,529
Cavanaugh SarahSVP of Corp Affairs & Admin.11/01/202147,852
Cavanaugh SarahSVP of Corp Affairs & Admin.11/01/2021316,804
Crowley ElizabethSr. VP &CPDO11/01/202123,783
Crowley ElizabethSr. VP &CPDO11/01/2021186,874
Heath-Chiozzi MargoSVP of Regulatory Affairs11/01/20211,668
Heath-Chiozzi MargoSVP of Regulatory Affairs11/01/202125,026
Heath-Chiozzi MargoSVP of Regulatory Affairs08/11/202190,165
Jimenez Freddy A.SVP & General Counsel08/11/202119,900
Martin Samuel BatesSVP and CFO08/10/2021123,688
Martin Samuel BatesSVP and CFO08/10/2021123,895
Marucci Anthony SPresident & CEO08/05/2021148,554
Wright Richard M.Sr. VP & CCO12/14/2020129,365
Wright Richard M.Sr. VP & CCO12/14/2020387,611
Young Diane C.SVP, Chief Medical Officer06/11/202010,004
Cavanaugh SarahSVP of Corp Affairs & Admin.06/10/20205,071
Heath-Chiozzi MargoSVP of Regulatory Affairs06/09/20203,005
Martin Samuel BatesSVP and CFO06/09/202029,737
MARINO JAMES JDirector06/09/202024,915
KELER TIBORExecutive VP & CSO06/09/202014,954
Marucci Anthony SPresident & CEO06/09/202045,900
McMahon Gerald PhDDirector12/03/2018843
McMahon Gerald PhDDirector11/01/2018908
McMahon Gerald PhDDirector10/01/20181,302
McMahon Gerald PhDDirector09/04/20181,412
MARINO JAMES JDirector08/24/201819,200
McMahon Gerald PhDDirector08/01/20181,308
McMahon Gerald PhDDirector07/02/20181,417
KELER TIBORExecutive VP & CSO06/15/20189,783
McMahon Gerald PhDDirector06/01/20181,632
McMahon Gerald PhDDirector05/01/20182,082
McMahon Gerald PhDDirector04/02/20187,873
McMahon Gerald PhDDirector03/01/20187,684
McMahon Gerald PhDDirector02/01/20189,425
McMahon Gerald PhDDirector01/02/201810,409
McMahon Gerald PhDDirector12/01/20179,636
McMahon Gerald PhDDirector11/01/20177,837
McMahon Gerald PhDDirector10/02/20179,186
McMahon Gerald PhDDirector09/01/20177,902
McMahon Gerald PhDDirector08/01/20176,570
McMahon Gerald PhDDirector07/03/20177,086
McMahon Gerald PhDDirector06/01/20178,119
McMahon Gerald PhDDirector05/01/20179,554
McMahon Gerald PhDDirector04/03/201710,357
McMahon Gerald PhDDirector03/01/2017116,562
CATLIN AVERY WSr. VP & CFO09/02/201628,000
KELER TIBORExecutive VP & CSO09/02/20169,960
CATLIN AVERY WSr. VP & CFO06/03/201668,811
CATLIN AVERY WSr. VP & CFO03/09/201642,000
CATLIN AVERY WSr. VP & CFO11/23/2015213,000
CATLIN AVERY WSr. VP & CFO11/23/2015450,000
CATLIN AVERY WSr. VP & CFO09/11/201545,000
ELLBERGER LARRYDirector08/25/201570,000
ELLBERGER LARRYDirector08/20/201575,000
ELLBERGER LARRYDirector08/18/201579,747
ELLBERGER LARRYDirector08/13/201582,950
Marucci Anthony SPresident and CEO08/13/201597,497
CATLIN AVERY WSr. VP & CFO06/15/2015213,000
CATLIN AVERY WSr. VP & CFO06/15/2015614,752
CATLIN AVERY WSr. VP & CFO09/08/201445,000
LIPTON KAREN SHOOSDirector12/06/2013144,660
LIPTON KAREN SHOOSDirector12/06/2013434,336
PENNER HARRY JRDirector12/06/2013144,660
PENNER HARRY JRDirector12/06/2013434,336
ELLBERGER LARRYDirector12/06/2013144,660
ELLBERGER LARRYDirector12/06/2013434,336
CATLIN AVERY WSr. VP & CFO12/06/20131,495,997
CATLIN AVERY WSr. VP & CFO12/06/20134,491,659
CATLIN AVERY WSr. VP & CFO07/01/20132,975
Marucci Anthony SPresident & CEO07/01/20132,975
KELER TIBORSr. VP & CSO08/11/201112,520
Marucci Anthony SPresident & CEO08/09/201136,160
CATLIN AVERY WSr. VP & CFO08/09/20114,780
Davis Thomas AndrewSr. VP & CMO09/16/20109,435
LIPTON KAREN SHOOSDirector09/16/201011,220
PAREKH RAJESH RDirector09/13/2010149,348
KELER TIBORSr. VP & CSO09/13/201017,600
Marucci Anthony SPresident & CEO09/10/201040,351
SHANNON TIMOTHY MDirector09/10/201017,049
SCHALLER CHARLES RDirector09/09/201017,250
PENNER HARRY JRDirector09/09/201010,470
CATLIN AVERY WSr. VP & CFO09/08/20107,016
Load More Insider Transactions
FUNDS WITH A POSITION IN CELLDEX THERAPEUTICS, INC.
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.4,690,7610.00393%3.96%Other
GEODE CAPITAL MANAGEMENT, LLC1,533,9560.00498%8.45%Other
D. E. SHAW & CO., INC.845,5600.03%47.52%Other
CANDRIAM S.C.A.317,5090.07%No changeOther
RENAISSANCE TECHNOLOGIES LLC42,7880.00269%-86.31%Other
BAKER BROS. ADVISORS LP247,6440.12%No changeOther
FISHER ASSET MANAGEMENT, LLC120,5440.00194%-2.66%Other
TUDOR INVESTMENT CORP ET AL67,3840.02%ExitedEvent Driven, Other
BALYASNY ASSET MANAGEMENT L.P.64,7690.00475%ExitedEvent Driven
ALPS ADVISORS INC51,3990.01%13.11%Other
MAGNETAR FINANCIAL LLC17,3900.01%61.36%Event Driven, Other
AQR CAPITAL MANAGEMENT LLC7,8570.00045%23.67%Other
CHANGE IN SHARES OUTSTANDING FOR CELLDEX THERAPEUTICS, INC.
STOCK BUYBACKS FOR CELLDEX THERAPEUTICS, INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2024
12/31/2023
13.07%
1Q
03/31/2024
09/30/2023
24.57%
2Q
03/31/2024
06/30/2023
24.59%
3Q
03/31/2024
03/31/2023
24.69%
4Q
03/31/2024
12/31/2022
24.90%
5Q
03/31/2024
09/30/2022
25.48%
6Q
03/31/2024
06/30/2022
25.90%
7Q
03/31/2024
03/31/2022
25.96%
8Q
03/31/2024
12/31/2021
25.97%
9Q
03/31/2024
09/30/2021
29.52%
10Q
03/31/2024
06/30/2021
48.60%
11Q
03/31/2024
03/31/2021
48.61%
12Q
03/31/2024
09/30/2020
49.88%
14Q
Load More

Period of Report: 03/31/2024

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2023
13.07%
1Q
09/30/2023
24.57%
2Q
06/30/2023
24.59%
3Q
03/31/2023
24.69%
4Q
12/31/2022
24.90%
5Q
09/30/2022
25.48%
6Q
06/30/2022
25.90%
7Q
03/31/2022
25.96%
8Q
12/31/2021
25.97%
9Q
09/30/2021
29.52%
10Q
06/30/2021
48.60%
11Q
03/31/2021
48.61%
12Q
09/30/2020
49.88%
14Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CELLDEX THERAPEUTICS, INC.
LOADING...